(19)
(11) EP 3 681 861 A1

(12)

(43) Date of publication:
22.07.2020 Bulletin 2020/30

(21) Application number: 18856459.5

(22) Date of filing: 12.09.2018
(51) International Patent Classification (IPC): 
C07D 205/00(2006.01)
A61K 31/341(2006.01)
A61P 29/00(2006.01)
A61K 31/167(2006.01)
A61K 45/06(2006.01)
C07F 9/568(2006.01)
(86) International application number:
PCT/US2018/050656
(87) International publication number:
WO 2019/055509 (21.03.2019 Gazette 2019/12)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 12.09.2017 US 201715702693

(71) Applicant: Ardea Biosciences, Inc.
San Diego, CA 92121 (US)

(72) Inventors:
  • NANAVATI, Payal
    San Diego, California 92121 (US)
  • HOEGSTEDT, Johan
    San Diego, California 92121 (US)
  • HALL, Jesse
    San Diego, California 92121 (US)

(74) Representative: HGF 
1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)

   


(54) CXCR-2 INHIBITORS FOR TREATING DISORDERS